Measles Outbreak Continues growing in South Carolina among Unvaccinated
As of Oct. 24, 2025, the South Carolina Department of Public Health (DPH) reported 33 cases of measles…
As of Oct. 24, 2025, the South Carolina Department of Public Health (DPH) reported 33 cases of measles…
On Oct. 23, 2025, GSK announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf)…
On Oct. 23, 2025, researchers at a Harvard Medical School laboratory announced they are uncertain how they will…
On. Oct. 23, 2025, Air pollution continues to exacerbate global health, including noncommunicable diseases and dementia, according to…
On Oct. 23, 2025, CareDx announced the publication of the second study from Surveillance HeartCare Outcomes Registry (SHORE)…
On Oct. 22, 2025, Alkermes and Avadel Pharmaceuticals announced the companies have entered into a definitive agreement under…
On Oct. 22, 2025, the South Carolina Department of Public Health (SCDPH) announced it is actively responding to…
On Oct. 22, 2025, a Roslin Institute led team announced they have developed pigs that are resistant to…
On Oct. 21, 2025, private equity firms Blackstone and TPG said they will buy medical diagnostics firm Hologic…
On Oct. 21, 2025, the Oregon Department of Agriculture has warned that as wild birds begin to migrate…
On Oct. 21, 2025, in the latest bid to plug gaps in the federal government’s public health infrastructure,…
On Oct. 20, 2025, the Millennium Seed Bank at the Royal Botanic Gardens Kew, located deep underground beneath…
On Oct. 20, 2025, Merck announced the start of construction for a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility…
On Oct. 20, 2025, Glaukos announced today the U.S. Food and Drug Administration (FDA) approved its Epioxa™ HD…
On Oct. 20, 2025, The Jackson Laboratory (JAX), a global leader in genetics and genomic medicine, announced it…
On Oct. 20, 2025, ACG, the world’s most integrated provider of solid-dosage solutions, announced a $200 million phased…
On Oct. 18, 2025, GRAIL announced that positive performance and safety results from its registrational PATHFINDER 2 study…
On Oct. 18, 2025, the Swiss Pharma giant F Hoffmann La Roche (Roche) suffered a setback as the…
On Oct. 17, 2025, Chinese biotech Hansoh Pharma said it had signed a license agreement worth up to…
On Oct. 17, 2025, Boston Scientific announced it has entered into a definitive agreement to acquire Nalu Medical,…
On Oct. 17, 2025, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved Rybelsus®, the only oral GLP-1…
On Oct. 16, 2025, the Food and Drug Administration (FDA) announced the first round of experimental drugs that…
On Oct. 15, 2025, mRNA COVID-19 vaccination in the first trimester of pregnancy isn’t tied to an elevated…
On Oct. 15, 2025, Broad Clinical Labs, in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, announced…
On Oct. 15, 2025, Danish drugmaker Novo Nordisk and Omeros announced they have signed a licensing deal worth…
On Oct. 14, 2025, researchers Texas A&M University School of Engineering Medicine (EnMed) announced development of a portable…
On Oct. 14, 2025, Japan’s health authorities have declared an influenza epidemic, with thousands of people infected with…
On Oct. 14, 2025, researchers at Cincinnati Children’s in collaboration with Roche, have developed a next-generation human liver…
On Oct. 13, 2025, researchers from Texas A&M University announced they have identified two estrogens, estradiol and estriol,…
On Oct. 13, 2025, the World Health Organization (WHO) reported that one in six laboratory-confirmed bacterial infections causing…